The launch of the 750mcg teriparatide injection in the Australian market has been phased. Currently, sales are managed through designated clinics and pharmacies, requiring a prescription from an physician. Obtaining this treatment is subject to strict guidelines and person assessment. Although the preliminary announcement of broader availability, i